Literature DB >> 11679994

Ethical considerations and rationale of adult-to-adult living donor liver transplantation.

M Malagó1, G Testa, A Marcos, J J Fung, M Siegler, D C Cronin, C E Broelsch.   

Abstract

Adult-to-adult living donor liver transplantation (ALDLT) is a reality; shortly after its introduction into clinical practice, it is being performed in approximately 50 centers throughout the United States and Europe. The quick development of ALDLT and some deaths among donors repropose old ethical dilemmas and confront the transplant community with new urgent problems. To minimize risks for recipients and, especially, donors, two key questions are addressed: (1) who can or should perform the procedure, and (2) what patient should undergo the procedure. The high risks taken by live donors undergoing a hemihepatectomy seem to be justified by the steadily increasing mortality of adult recipients waiting for transplantation. A comprehensive consent procedure is at the base of responsible decision making for both donors and recipients. In adherence to basic medical criteria, the autonomy of decision of donors and recipients may allow the extension of indications to patients not suitable to undergo transplantation with cadaveric grafts. The broadening of indications is appropriate only in centers with adequate experience and proven expertise in ALDLT. The medical community faces the duty of regulating ALDLT before external influences force undesired policy changes, particularly if not based on medical grounds. Individual centers and patients are ultimately responsible for the correct use of LDLT.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  2001        PMID: 11679994     DOI: 10.1053/jlts.2001.28301

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  9 in total

1.  [Evaluation of potential liver living donors. Logistic and financial aspects].

Authors:  D C Broering; P Bok; L Fischer; M Sterneck; X Rogiers
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955

2.  Role of living liver donation in the United Kingdom.

Authors:  James Neuberger; David Price
Journal:  BMJ       Date:  2003-09-20

3.  Live liver donors' risk thresholds: risking a life to save a life.

Authors:  Michele Molinari; Jacob Matz; Sarah DeCoutere; Karim El-Tawil; Bassam Abu-Wasel; Valerie Keough
Journal:  HPB (Oxford)       Date:  2013-11-20       Impact factor: 3.647

Review 4.  Ethical dilemmas related to living donor liver transplantation in Asia.

Authors:  Lubna Shazi; Zaigham Abbas
Journal:  Ir J Med Sci       Date:  2019-02-23       Impact factor: 1.568

5.  Right living donor liver transplantation: an option for adult patients: single institution experience with 74 patients.

Authors:  Massimo Malagó; Giuliano Testa; Andrea Frilling; Silvio Nadalin; Camino Valentin-Gamazo; Andreas Paul; Hauke Lang; Ulrich Treichel; Vito Cicinnati; Guido Gerken; Christoph Erich Broelsch
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

6.  Living donor liver transplantation.

Authors:  S Nadalin; M Bockhorn; M Malagó; C Valentin-Gamazo; A Frilling; C E Broelsch
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

7.  Historical perspective of living donor liver transplantation.

Authors:  See Ching Chan; Sheung Tat Fan
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

8.  Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison.

Authors:  Georgios C Sotiropoulos; Eleftherios Spartalis; Nikolaos Machairas; Andreas Paul; Massimo Malagó; Markus Neuhäuser
Journal:  Ann Gastroenterol       Date:  2018-07-27

9.  The outcomes of pediatric liver retransplantation from a living donor: a 17-year single-center experience.

Authors:  Kohei Miura; Seisuke Sakamoto; Keita Shimata; Masaki Honda; Takashi Kobayashi; Toshifumi Wakai; Yasuhiko Sugawara; Yukihiro Inomata
Journal:  Surg Today       Date:  2017-04-22       Impact factor: 2.549

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.